Medicare Enrolled
Dr. Bradley Frasier, MD
Optician · Oceanside, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Frasier from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Frasier?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Frasier
Dr. Bradley Frasier is an optician specialist in Oceanside, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Frasier performed 2,445 Medicare services across 1,424 unique beneficiaries.
Between the years covered by Open Payments, Dr. Frasier received a total of $12,571 from 66 pharmaceutical and/or device companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Frasier is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 32% volume in CA
$12,571 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,445
Medicare services
Top 32% in CA for optician
1,424
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~129 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
742 | $102 | $150 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
413 | $84 | $151 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
302 | $72 | $125 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
247 | $4 | $10 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 164 | $133 | $600 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
103 | $209 | $301 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $123 | $203 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
63 | $43 | $79 |
| Functional capacity test, per 15 minutes A test or measurement to assess functional capacity. The service is billed for each 15-minute increment. |
56 | $25 | $70 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
52 | $149 | $201 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
42 | $12 | $35 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $31 | $50 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
21 | $120 | $176 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
20 | $192 | $455 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
20 | $47 | $275 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $72 | $153 |
| New patient office visit, complex (60-74 min) | 16 | $169 | $330 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
13 | $348 | $500 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
13 | $6 | $58 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
13 | $28 | $102 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
13 | $176 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,571
Total received (2018-2024)
Avg $1,796/year across 7 years
Top 12% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
560
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,907 (86.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,664 (13.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,344
2023
$1,958
2022
$1,705
2021
$2,454
2020
$1,428
2019
$1,770
2018
$912
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BIOTISSUE HOLDINGS INC.
$408
Dendreon Pharmaceuticals LLC
$403
Janssen Biotech, Inc.
$189
ABBVIE INC.
$134
INTUITIVE SURGICAL, INC.
$132
Olympus America Inc.
$116
COLOPLAST CORP
$106
ACCORD HEALTHCARE, INC.
$96
Sumitomo Pharma America, Inc.
$84
UROGEN PHARMA, INC.
$72
Telix Pharmaceuticals
$66
Astellas Pharma US Inc
$63
Bayer Healthcare Pharmaceuticals Inc.
$62
Blue Earth Diagnostics Limited
$54
AstraZeneca Pharmaceuticals LP
$51
Teleflex LLC
$40
Myriad Genetic Laboratories, Inc.
$36
PFIZER INC.
$33
PROCEPT BioRobotics Corporation
$33
Novartis Pharmaceuticals Corporation
$32
PROGENICS PHARMACEUTICALS, INC.
$28
Tempus AI, Inc
$25
C. R. Bard, Inc. & Subsidiaries
$23
Endo Pharmaceuticals Inc.
$20
IMMUNITYBIO, INC.
$20
Ethicon US, LLC
$19
Top 3 companies account for 42.7% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,768
Janssen Biotech, Inc.
$1,570
Dendreon Pharmaceuticals LLC
$1,307
PFIZER INC.
$546
Allergan, Inc.
$545
Myriad Genetic Laboratories, Inc.
$438
BIOTISSUE HOLDINGS INC.
$408
ABBVIE INC.
$385
Endo Pharmaceuticals Inc.
$372
Coloplast Corp
$366
Myovant Sciences Inc.
$314
AbbVie, Inc.
$265
Blue Earth Diagnostics Limited
$248
UroGen Pharma, Inc.
$228
Amgen Inc.
$210
AstraZeneca Pharmaceuticals LP
$194
Bayer HealthCare Pharmaceuticals Inc.
$193
COLOPLAST CORP
$186
Olympus America Inc.
$167
Sumitomo Pharma America, Inc.
$140
Bayer Healthcare Pharmaceuticals Inc.
$137
Progenics Pharmaceuticals, Inc.
$136
INTUITIVE SURGICAL, INC.
$132
Novartis Pharmaceuticals Corporation
$128
AbbVie Inc.
$125
Acerus Pharmaceuticals Corporation
$125
ACCORD HEALTHCARE, INC.
$119
180 Medical, Inc.
$105
Merck Sharp & Dohme LLC
$103
Telix Pharmaceuticals
$101
Hollister Incorporated
$101
UROGEN PHARMA, INC.
$92
Teleflex LLC
$91
Ferring Pharmaceuticals Inc.
$82
PROCEPT BioRobotics Corporation
$78
Allergan Inc.
$76
Alnylam Pharmaceuticals Inc.
$71
Duchesnay USA Incorporated
$68
UROVANT SCIENCES INC
$65
C. R. Bard, Inc. & Subsidiaries
$65
Foundation Medicine, Inc.
$61
MEDIVATION FIELD SOLUTIONS LLC
$60
ABC Home Medical Supply, Inc.
$60
Merck Sharp & Dohme Corporation
$47
Sagent Pharmaceuticals, Inc.
$45
DAVOL INC.
$44
Rochester Medical Corporation
$37
Palette Life Sciences, Inc.
$32
PROGENICS PHARMACEUTICALS, INC.
$28
TerSera Therapeutics LLC
$25
Tempus AI, Inc
$25
Innovation Technologies Inc
$22
Metuchen Pharmaceuticals
$21
Sun Pharmaceutical Industries Inc.
$20
IMMUNITYBIO, INC.
$20
Davol Inc.
$19
Ethicon US, LLC
$19
Axonics, Inc.
$18
Abbott Laboratories
$17
ConvaTec Inc.
$17
Avadel Specialty Pharmaceuticals, LLC
$17
BOSTON SCIENTIFIC CORPORATION
$16
Antares Pharma, Inc.
$16
Boston Scientific Corporation
$14
Supernus Pharmaceuticals, Inc.
$13
NxThera, Inc.
$10
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARISTA AH · AVEED · Axium INS DRG IPG · Axonics · Axumin · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · CURE CATHETER · DIGITEX · Da Vinci Surgical System · EDEX · ERLEADA · ETHICON · Erleada · FOUNDATIONONE · GEMTESA · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · GentleCath · Glydo · ILLUCCIX · IRRISEPT · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Luja Coude · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ONLI · ORGOVYX · OXLUMO · Olympus Cysto-Resection · Osphena · PLUVICTO · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PVC · PYLARIFY · Progel · Prolaris · Prolia · RETRACE · RYBREVANT · Rezum · SPEEDICATH · Saffron · SpeediCath · Stendra · TITAN · TLANDO · TOVIAZ · Titan · UROLIFT · UroLift System · VAPRO · VaPro Plus Pocket · Veozah · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · ZOLADEX · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
238
Per 100K population
7.2
County median income
$102,285
Nearest hospital
TRI-CITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Frasier is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Frasier experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Frasier performed 742 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Frasier receive payments from pharmaceutical companies?
Yes. Dr. Frasier received a total of $12,571 from 66 companies across 560 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Frasier's costs compare to other opticians in Oceanside?
Dr. Frasier's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Frasier) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Oceanside
Browse opticians in Oceanside ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology